Improving weight loss in young adults by extending sleep duration
Sleep Extension: A Novel Intervention for Weight Loss in Young Adults
This study is looking at whether getting more sleep can help young adults who usually sleep less than 6.5 hours a night lose weight, by comparing those who just change their lifestyle to those who also get extra sleep.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10922859 on NIH RePORTER |
What this research studies
This research investigates how extending sleep duration can aid in weight loss for young adults who typically sleep less than 6.5 hours a night. The study will involve a randomized clinical trial where participants will receive either lifestyle intervention alone or a combination of lifestyle intervention and sleep extension. By focusing on the relationship between sleep and eating behaviors, the research aims to determine if better sleep can lead to reduced caloric intake and improved weight loss outcomes. Participants will be monitored using accelerometers and mobile applications to track their sleep patterns and behaviors.
Who could benefit from this research
Good fit: Ideal candidates for this research are overweight young adults aged 18-30 who habitually sleep less than 6.5 hours per night.
Not a fit: Patients who are not overweight or those who already maintain healthy sleep patterns may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel approach to weight loss that emphasizes the importance of sleep, potentially leading to better health outcomes for young adults.
How similar studies have performed: While the concept of sleep extension as a weight loss strategy is relatively novel, preliminary evidence suggests that improving sleep may positively influence weight management.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Tasali, Esra — University of Chicago
- Study coordinator: Tasali, Esra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.